ValuEngine Upgrades Intuitive Surgical (NASDAQ:ISRG) to Sell

ValuEngine upgraded shares of Intuitive Surgical (NASDAQ:ISRG) from a strong sell rating to a sell rating in a research note released on Tuesday, ValuEngine reports.

Other research analysts also recently issued reports about the stock. Raymond James boosted their price objective on shares of Intuitive Surgical from $610.00 to $625.00 and gave the company a buy rating in a research report on Friday, October 18th. UBS Group increased their price target on shares of Intuitive Surgical from $560.00 to $590.00 and gave the stock a neutral rating in a research note on Friday, October 18th. Morgan Stanley set a $620.00 price objective on shares of Intuitive Surgical and gave the stock a buy rating in a report on Friday, October 18th. Zacks Investment Research raised Intuitive Surgical from a hold rating to a buy rating and set a $601.00 price objective on the stock in a research report on Thursday, November 21st. Finally, Royal Bank of Canada set a $570.00 target price on Intuitive Surgical and gave the stock a hold rating in a report on Friday, October 18th. Two investment analysts have rated the stock with a sell rating, four have assigned a hold rating, eleven have issued a buy rating and one has issued a strong buy rating to the company’s stock. The stock currently has an average rating of Buy and an average price target of $587.62.

ISRG opened at $579.23 on Tuesday. The business has a 50 day simple moving average of $561.88 and a two-hundred day simple moving average of $524.47. The firm has a market capitalization of $68.52 billion, a price-to-earnings ratio of 61.04, a PEG ratio of 4.44 and a beta of 1.13. Intuitive Surgical has a one year low of $430.24 and a one year high of $594.16.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $3.43 earnings per share for the quarter, topping the Zacks’ consensus estimate of $2.99 by $0.44. Intuitive Surgical had a return on equity of 18.26% and a net margin of 30.94%. The firm had revenue of $1.13 billion for the quarter, compared to analyst estimates of $1.06 billion. During the same period last year, the company earned $2.83 EPS. The business’s quarterly revenue was up 22.5% compared to the same quarter last year. On average, analysts anticipate that Intuitive Surgical will post 10.98 earnings per share for the current fiscal year.

In related news, Director Lonnie M. Smith sold 205 shares of the company’s stock in a transaction dated Friday, November 8th. The shares were sold at an average price of $554.49, for a total value of $113,670.45. Following the transaction, the director now owns 368,952 shares in the company, valued at approximately $204,580,194.48. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, SVP Jamie Samath sold 1,021 shares of the stock in a transaction dated Tuesday, October 22nd. The shares were sold at an average price of $557.15, for a total transaction of $568,850.15. Following the sale, the senior vice president now directly owns 446 shares in the company, valued at $248,488.90. The disclosure for this sale can be found here. In the last 90 days, insiders sold 12,726 shares of company stock worth $7,036,366. Corporate insiders own 1.70% of the company’s stock.

A number of institutional investors and hedge funds have recently modified their holdings of the business. Nuveen Asset Management LLC lifted its holdings in shares of Intuitive Surgical by 32,872.7% during the second quarter. Nuveen Asset Management LLC now owns 1,847,791 shares of the medical equipment provider’s stock valued at $969,259,000 after purchasing an additional 1,842,187 shares in the last quarter. Morgan Stanley lifted its position in Intuitive Surgical by 39.1% during the second quarter. Morgan Stanley now owns 4,288,986 shares of the medical equipment provider’s stock valued at $2,249,785,000 after purchasing an additional 1,204,750 shares during the period. Coatue Management LLC purchased a new stake in Intuitive Surgical in the second quarter worth approximately $302,483,000. Vanguard Group Inc. lifted its holdings in shares of Intuitive Surgical by 2.0% during the 2nd quarter. Vanguard Group Inc. now owns 8,826,059 shares of the medical equipment provider’s stock valued at $4,629,709,000 after buying an additional 169,521 shares during the period. Finally, Stonehage Fleming Financial Services Holdings Ltd bought a new stake in shares of Intuitive Surgical in the second quarter worth $84,805,000. Institutional investors and hedge funds own 85.59% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. Its da Vinci Surgical System transforms the surgeon's natural hand movements outside the body into corresponding micro-movements inside the patient's body. The company's da Vinci Surgical System include surgeon's consoles, patient-side carts, 3-D vision systems, da Vinci skills simulators, da Vinci Xi integrated table motions, and Firefly fluorescence imaging products that enable surgeons to perform various surgical procedures, including gynecologic, urologic, general, cardiothoracic, and head and neck surgical procedures.

Read More: Leveraged Buyout (LBO) Explained

To view ValuEngine’s full report, visit ValuEngine’s official website.

Analyst Recommendations for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.